TIBCO Software Inc., together with INTEGROMICS, a provider of state-of-the-art software solutions for data management and data analysis in genomics, proteomics and drug discovery, today announced Integromics Biomarker Discovery 2.0 for TIBCO Spotfire®, a new solution that sets the standard for advanced methods of data access, normalization, pattern detection, treatment comparison, and functional analysis for scientists analyzing genomic expression data. This powerful platform plays a pivotal role in leveraging the substantial investment in gene expression technologies that the pharmaceutical and biotechnology industries have made in the last decade. Gaining new insights into disease biology, mechanism of action, and drug safety will be a key differentiator in early drug discovery.

Article sourced from www.marketwire.com.com, click here to read full story.